Merck Acquires Caraway Therapeutics in a Landmark $610 Million Deal
Key Highlights Merck to acquire Caraway Therapeutics, a biopharmaceutical company focusing on neurodegenerative and rare diseases, for a…
Browsing Tag
Caraway Therapeutics
1 post